PHARM TECH JAPAN 2026年3月号(Vol.42 No.3)
This issue focuses on reviewing the nitrosamine issue and its future developments, considering the lessons learned since the problem was discovered and the ongoing need for proper management of nitrosamines.
- The description claims that the nitrosamine issue continues to impact the industry despite autonomous inspection deadlines.
Variants (1)
- Default Title — 2530.00 JPY — In stock
AI Readiness
Good foundation, but some important product data is still missing.
83%